Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05386069 · ClinicalTrials.gov registry record · Phase 3
Does a Non-Opioid Multimodal Pain (NOMO) Protocol Decrease Narcotic Use
A Phase 3 study, sponsored by Prisma Health-Upstate.
- Completed
- Registry status
- Phase 3
- Development phase
- 10
- Enrollment target
NCT05386069: Completed Phase 3 study, sponsored by Prisma Health-Upstate.
NCT05386069 is a Phase 3 study that has completed, run by Prisma Health-Upstate. The registered enrollment target is 10 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05386069, a Phase 3 study, has completed, sponsored by Prisma Health-Upstate.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 10 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate narcotic use after implementation of a Non-Opioid Multimodal Pain (NOMO) protocol in patients who are undergoing a urogynecologic procedure. The study will also evaluate secondary outcomes, including: post-operative pain rating, length of hospital stay, postoperative antiemetic use, bladder catheterization at discharge, number of post-operative phone calls, and rate of reported side effects of opioid use (nausea/constipation). Study participants will be asked to utilize the validated Brief Pain Inventory (appendix A) scale to assess post-operative pain levels. Based on inpatient post-operative opioid use and number of opioid pills prescribed at discharge, an attempt will be made to develop an algorithm for recommended opioid prescribing patterns.
Primary Outcome
Total morphine milligram equivalents calculated for each patient during their stay.
Interventions
- DRUG NOMO Protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-11-15 |
| Est. Completion | 2021-06-01 |
| Phase | Phase 3 |
What the finished NCT05386069 record still lists
NCT05386069 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which NOMO Protocol is the first listed.
NCT05386069 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05386069 about?
NCT05386069 is a clinical study titled "Does a Non-Opioid Multimodal Pain (NOMO) Protocol Decrease Narcotic Use". The objective of this study is to evaluate narcotic use after implementation of a Non-Opioid Multimodal Pain (NOMO) protocol in patients who are undergoing a urogynecologic procedure. The study will also evaluate secondary outcomes, including: post-operative pain rating, length of hospital stay, pos...
What is the current status of trial NCT05386069?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 10 participants. The study started on 2019-11-15. Estimated completion is 2021-06-01.
What interventions are being tested in trial NCT05386069?
The interventions under investigation include: NOMO Protocol (DRUG).
Who is sponsoring clinical trial NCT05386069?
This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05386069's enrollment target sits among peer trials
10 1989th of 2000 higher than 9 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI